Bactobolin resistance is conferred by mutations in the L2 ribosomal protein

mBio

Volumn 3, Issue 6, 2012, Pages

  Chandler, Josephine R ^a   Truong, Thao T ^a   Silva, Patricia M ^a,c   Seyedsayamdost, Mohammad R ^b   Carr, Gavin ^b   Radey, Matthew ^a   Jacobs, Michael A ^a   Sims, Elizabeth H ^a   Clardy, Jon ^b   Greenberg, E Peter ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTOBOLIN; BACTOBOLIN A; BACTOBOLIN B; BACTOBOLIN C; CHLORAMPHENICOL; CLINDAMYCIN; KANAMYCIN; L2 RIBOSOMAL PROTEIN; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BACTERIUM MUTANT; BURKHOLDERIA THAILANDENSIS; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; GENE EXPRESSION; GENE INSERTION; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC CONSERVATION; GENOME SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RPLB GENE; SEQUENCE ALIGNMENT; THERMOREGULATION;

BACILLUS SUBTILIS; BURKHOLDERIA THAILANDENSIS; EUKARYOTA; MAMMALIA;

EID: 84872132513     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00499-12     Document Type: Article

References (69)

1. Biggins JB, Ternei MA, Brady SF. 2012. Malleilactone, a polyketide synthase-derived virulence factor encoded by the cryptic secondary metabolome of Burkholderia pseudomallei group pathogens. J. Am. Chem. Soc. 134:13192-13195.
2. Carr G, Seyedsayamdost MR, Chandler JR, Greenberg EP, Clardy J. 2011. Sources of diversity in bactobolin biosynthesis by Burkholderia thailandensis E264. Org. Lett. 13:3048-3051.
3. Seyedsayamdost MR, et al. 2010. Quorum-sensing-regulated bactobolin production by Burkholderia thailandensis E264. Org. Lett. 12:716-719.
4. Kondo S, Horiuchi Y, Hamada M, Takeuchi T, Umezawa H. 1979. A new antitumor antibiotic, bactobolin produced by Pseudomonas. J. Antibiot. (Tokyo) 32:1069-1071.
5. Munakata T, Sakai J, Matsuki H, Isagai Km. 1981. Bactobolins, antitumor antibiotics from Pseudomonas. I. Structures and antimicrobial activities (author's transl). Yakugaku Zasshi 101:132-137. (In Japanese.)
6. Duerkop BA, et al. 2009. Quorum-sensing control of antibiotic synthesis in Burkholderia thailandensis. J. Bacteriol. 191:3909-3918.
7. Hori M, Suzukake K, Ishikawa C, Asakura H, Umezawa H. 1981. Biochemical studies on bactobolin in relation to actinobolin. J. Antibiot. (Tokyo) 34:465-468.
8. McCoy LS, Xie Y, Tor Y. 2011. Antibiotics that target protein synthesis. Wiley Interdiscip. Rev. RNA 2:209-232.
9. Poehlsgaard J, Douthwaite S. 2005. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3:870-881.
10. Davidovich C, Bashan A, Yonath A. 2008. Structural basis for crossresistance to ribosomal PTC antibiotics. Proc. Natl. Acad. Sci. U. S. A. 105:20665-20670.
11. Skinner R, Cundliffe E, Schmidt FJ. 1983. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J. Biol. Chem. 258:12702-12706.
12. Albers CA, et al. 2011. Dindel: accurate indel calls from short-read data. Genome Res. 21:961-973.
13. Müller EC, Wittmann-Liebold B. 1997. Phylogenetic relationship of organisms obtained by ribosomal protein comparison. Cell. Mol. Life Sci. 53:34-50.
14. Diedrich G, et al. 2000. Ribosomal protein L2 is involved in the association of the ribosomal subunits, tRNA binding to A and P sites and peptidyl transfer. EMBO J. 19:5241-5250.
15. Hampl H, Schulze H, Nierhaus KH. 1981. Ribosomal components from Escherichia coli 50 S subunits involved in the reconstitution of peptidyltransferase activity. J. Biol. Chem. 256:2284-2288.
16. Khaitovich P, Mankin AS, Green R, Lancaster L, Noller HF. 1999. Characterization of functionally active subribosomal particles from Thermus aquaticus. Proc. Natl. Acad. Sci. U. S. A. 96:85-90.
17. Schulze H, Nierhaus KH. 1982. Minimal set of ribosomal components for reconstitution of the peptidyltransferase activity. EMBO J. 1:609-613.
18. Uhlein M, Weglöhner W, Urlaub H, Wittmann-Liebold B. 1998. Functional implications of ribosomal protein L2 in protein biosynthesis as shown by in vivo replacement studies. Biochem. J. 331(Part 2):423-430.
19. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. 2000. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 289:905-920.
20. Harms J, et al. 2001. High resolution structure of the large ribosomal subunit from a mesophilic Eubacterium. Cell 107:679-688.
21. Nakagawa A, et al. 1999. The three-dimensional structure of the RNAbinding domain of ribosomal protein L2; a protein at the peptidyl transferase center of the ribosome. EMBO J. 18:1459-1467.
22. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. 2000. The structural basis of ribosome activity in peptide bond synthesis. Science 289:920-930.
23. Agmon I, Bashan A, Zarivach R, Yonath A. 2005. Symmetry at the active site of the ribosome: structural and functional implications. Biol. Chem. 386:833-844.
24. Egebjerg J, Christiansen J, Garrett RA. 1991. Attachment sites of primary binding proteins L1, L2 and L23 on 23 S ribosomalRNAof Escherichia coli. J. Mol. Biol. 222:251-264.
25. Gulle H, et al. 1988. RNA-protein cross-linking in Escherichia coli 50S ribosomal subunits; determination of sites on 23S RNA that are crosslinked to proteins L2, L4, L24 and L27 by treatment with 2-iminothiolane. Nucleic Acids Res. 16:815-832.
26. Kitahara K, Kajiura A, Sato NS, Suzuki T. 2007. Functional genetic selection of helix 66 in Escherichia coli 23S rRNA identified the eukaryoticbinding sequence for ribosomal protein L2. Nucleic Acids Res. 35: 4018-4029.
27. Cooperman BS, Wooten T, Romero DP, Traut RR. 1995. Histidine 229 in protein L2 is apparently essential for 50S peptidyl transferase activity. Biochem. Cell Biol. 73:1087-1094.
28. Adrian PV, et al. 2000. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob. Agents Chemother. 44:732-738.
29. Bollen A, Cabezón T, de Wilde M, Villarroel R, Herzog A. 1975. Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. I. General properties of neaA mutants. J. Mol. Biol. 99:795-806.
30. Buckel P, Buchberger A, Böck A, Wittmann HG. 1977. Alteration of ribosomal protein L6 in mutants of Escherichia coli resistant to gentamicin. Mol. Gen. Genet. 158:47-54.
31. Dabbs ER. 1980. The ribosomal components responsible for kasugamycin dependence, and its suppression, in a mutant of Escherichia coli. Mol. Gen. Genet. 177:271-276.
32. Funatsu G, Nierhaus K, Wittmann-Liebold B. 1972. Ribosomal proteins. XXII. Studies on the altered protein S5 from a spectinomycin-resistant mutant of Escherichia coli. J. Mol. Biol. 64:201-209.
33. Funatsu G, Wittmann HG. 1972. Ribosomal proteins. 33. Location of amino-acid replacements in protein S12 isolated from Escherichia coli mutants resistant to streptomycin. J. Mol. Biol. 68:547-550.
34. Piepersberg W, Böck A, Yaguchi M, Wittmann HG. 1975. Genetic position and amino acid replacements of several mutations in ribosomal protein S5 from Escherichia coli. Mol. Gen. Genet. 143:43-52.
35. Wienen B, et al. 1979. Ribosomal protein alterations in thiostrepton- and micrococcin-resistant mutants of Bacillus subtilis. J. Biol. Chem. 254: 8031-8041.
36. Wittmann HG, et al. 1973. Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol. Gen. Genet. 127:175-189.
37. Yaguchi M, et al. 1976. Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. II. Localization of the amino acid replacement in protein S17 from a meaA mutant. J. Mol. Biol. 104:617-620.
38. Belova L, Tenson T, Xiong L, McNicholas PM, Mankin AS. 2001. A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit. Proc. Natl. Acad. Sci. U. S. A. 98: 3726-3731.
39. Harms JM, et al. 2008. Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Mol. Cell 30:26-38.
40. Allen PN, Noller HF. 1989. Mutations in ribosomal proteins S4 and S12 influence the higher order structure of 16 S ribosomal RNA. J. Mol. Biol. 208:457-468.
41. Davies C, et al. 1998. Ribosomal proteins S5 and L6: high-resolution crystal structures and roles in protein synthesis and antibiotic resistance. J. Mol. Biol. 279:873-888.
42. Davydova N, Streltsov V, Wilce M, Liljas A, Garber M. 2002. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin. J. Mol. Biol. 322:635-644.
43. Schlünzen F, et al. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.
44. Cundliffe E. 1990. The ribosome: structure, function, and evolution. American Society for Microbiology, Washington, DC.
45. Brett PJ, DeShazer D, Woods DE. 1998. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48: 317-320. doi: 10.1099/00207713-48-1-317.
46. Conn HJ. 1930. The identity of Bacillus subtilis. J. Infect. Dis. 46:341-350.
47. Perego M, Hoch JA. 1987. Isolation and sequence of the spo0E gene: its role in initiation of sporulation in Bacillus subtilis. Mol. Microbiol. 1:125-132.
48. Sambrook JE, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
49. Chandler JR, et al. 2009. Mutational analysis of Burkholderia thailandensis quorum sensing and self-aggregation. J. Bacteriol. 191:5901-5909.
50. Ben-Yehuda S, Rudner DZ, Losick R. 2003. RacA, a bacterial protein that anchors chromosomes to the cell poles. Science 299:532-536.
51. Griffith KL, Grossman AD. 2008. Inducible protein degradation in Bacillus subtilis using heterologous peptide tags and adaptor proteins to target substrates to the protease ClpXP. Mol. Microbiol. 70:1012-1025.
52. Sonenshein AL, Cami B, Brevet J, Cote R. 1974. Isolation and characterization of rifampin-resistant and streptolydigin-resistant mutants of Bacillus subtilis with altered sporulation properties. J. Bacteriol. 120: 253-265.
53. Hayden HS, et al. 2012. Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One 7:e36507. http://dx.doi.org/10.1371/journal.pone.0036507.
54. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-1760.
55. Robinson JT, et al. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24-26.
56. Mahenthiralingam E, et al. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913.
57. Nierman WC, et al. 2004. Structural flexibility in the Burkholderia mallei genome. Proc. Natl. Acad. Sci. U. S. A. 101:14246-14251.
58. DeShazer D, Brett PJ, Carlyon R, Woods DE. 1997. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J. Bacteriol. 179:2116-2125.
59. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. 1990. Personto- person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
60. Zeng S, Wu LC, Lehmann PF. 1996. Random amplified polymorphic DNA analysis of culture collection strains of Candida species. J. Med. Vet. Mycol. 34:293-297.
61. Mcclean KH, et al. 1997. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143:3703-3711.
62. Peterson SB, Dunn AK, Klimowicz AK, Handelsman J. 2006. Peptidoglycan from bacillus cereus mediates commensalism with rhizosphere bacteria from the Cytophaga-Flavobacterium group. Appl. Environ. Microbiol. 72:5421-5427.
63. Fang FC, Sandler N, Libby SJ. 2005. Liver abscess caused by magA+ Klebsiella pneumoniae in North America. J. Clin. Microbiol. 43:991-992.
64. Ramakrishnan L, Valdivia RH, McKerrow JH, Falkow S. 1997. Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect. Immun. 65:767-773.
65. Pearson MM, et al. 2008. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190:4027-4037.
66. Rahme LG, et al. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902.
67. Thomashow LS, Weller DM. 1988. Role of a phenazine antibiotic from Pseudomonas fluorescens in biological control of Gaeumannomyces graminis var. tritici. J. Bacteriol. 170:3499-3508.
68. Ralston E, Palleroni NJ, Doudoroff M. 1973. Pseudomonas pickettii, a new species of clinical origin related to Pseudomonas solanecearum. Int. J. Syst. Evol. Microbiol. 23:15-19.
69. Sumby P, et al. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771-782.